130 likes | 297 Views
SPARCL was designed to evaluate whether high-dose statin treatment reduces risk of stroke in patients with a recent stroke or TIA and no history of coronary heart disease. SPARCL: Background and rationale. Patients with prior stroke/TIA are at risk for future cardiovascular (CV) eventsStatins ?str
E N D
1. SPARCL Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial